EP4491176A1 — A film coated tablet comprising brivaracetam
Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2025-01-15 · 1y expired
What this patent protects
The present invention relates to a film coated tablet comprising brivaracetam and at least one pharmaceutically acceptable excipient wherein microcrystalline cellulose as diluent is present and the amount of disintegrant is 4.0% to 10.0% by weight in the total composition. Furthe…
USPTO Abstract
The present invention relates to a film coated tablet comprising brivaracetam and at least one pharmaceutically acceptable excipient wherein microcrystalline cellulose as diluent is present and the amount of disintegrant is 4.0% to 10.0% by weight in the total composition. Furthermore, the tablet is also obtained by using an effective process which is simple, rapid, cost effective, time-saving and industrially convenient process.
Drugs covered by this patent
- Briviact (BRIVARACETAM) · UCB
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.